Youle M, Osio M, Group AS
The safety and effectiveness of RYBELSUS was evaluated in a 26-week clinical study that included 324 patients with moderate renal impairment (eGFR 30 to 59 mL/min/1.73 m2) [see Clinical Studies (14.1)]
Burwinkel B, Kreuder J, Schweitzer S, Vorgerd M, Gempel K, Gerbitz KD, Kilimann MW: Carnitine transporter OCTN2 mutations in systemic primary carnitine deficiency: a novel Arg169Gln mutation and a recurrent Arg282ter mutation associated with an unconventional splicing abnormality
Last, our previous studies confirmed that LPS enhanced Ca 2+ influx, as mediated by TRPA1 in OA-FLS [24]
Semaglutide May Help Lower Blood Pressure Another possible benefit of semaglutide is lower blood pressure